Navigation Links
Elsevier is Expanding eClinical Solutions in Europe
Date:10/31/2008

COPENHAGEN, Denmark, October 31 /PRNewswire-FirstCall/ --

- DoctorConsult in Germany Marks First of Several Localized Workflow Solutions That Improve Clinician Decision Making and Health Care Business Performance

With a deep understanding of healthcare workflow and more than a century of experience as a global medical publisher, Elsevier is increasing its efforts to provide interactive clinical reference and clinical decision support (CDS) tools to new markets in Europe. With the launch of DoctorConsult - the German language version of MD Consult ( http://www.doctorconsult.de) -- Elsevier becomes the first multi-lingual professional clinical reference product provider.

The customized products meet the cultural needs of users who do not speak English as a first language, and address specific medical practice needs within different countries. The internet-based products provide users with a full range of medical information covering a variety of clinical needs. In one integrated interface, users can access evidence-based immediately actionable 'quick answers' (i.e. Elsevier's FirstConsult) as well as background references such as books and full text journal articles suitable for more in depth research and education needs. Additional localized versions of MD Consult are in development for Italy, France and Spain.

The Consult suite of multilingual reference products is just one of several solutions being developed to meet local reference, point-of-care, workflow and decision support needs. Additional solutions in development include:

- Clinical Decision Support:

- Guidelines and best practice information delivered when and where

they are most useful at the point of care

- Leveraging of patient data to pinpoint the most needed information

for a given clinical task

- Drug information and safety checking, also linked to patient data

when possible

- Seamless content integration with Electronic Health Records, including

infobuttons and alerts

- Payer services:

- Retrospective analytics for identifying performance gaps and outliers

- Tools to influence provider behavior (CDS solutions)

"Elsevier has been transforming CDS technology to offer a higher level of usability, primarily in the U.S. and now more so in Europe," said Jose Wehnes, Managing Director of the International Division of Elsevier Health Sciences. "Elsevier knowledge solutions, from drug information and actionable decision support, to process improvement and predictive analysis, have the potential to help deliver timely and appropriate information to clinicians in any country as they make critical diagnostic and therapeutic decisions throughout their workday."

Capturing 'e' Opportunities

Elsevier is uniquely positioned to replicate its success in the U.S. abroad. Market dynamics are different, as European E-Health markets and Elsevier's positions within them are at an earlier stage of development than in the U.S. However, key underlying market forces are similar to those in the U.S, particularly the drive to contain costs and improve outcomes, and the rapid increase in internet usage by physicians and other healthcare practitioners.

"By building upon our core strengths in leading content to provide information and workflow solutions, we can improve outcomes and efficiencies for both payers and providers on a country by country basis," said Wehnes. "Growing Elsevier Clinical Decision Support in Europe reinforces Elsevier's broader business strategy to strengthen its lead in core content, drive the transition of print materials to e-formats and deliver solutions directly into the clinical process."

Come by booth #625 at the World of Health IT Conference in Copenhagen, Denmark November 4-6, 2008 to learn more.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult ( http://www.mdconsult.com/), Mosby Nursing Consult ( http://www.nursingconsult.com) Scopus (http://www.info.scopus.com/), bibliographic databases and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Tom Reller

Director of Corp. Relations, Elsevier

+1-212-462-1912

T.Reller@Elsevier.com


'/>"/>
SOURCE Elsevier
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting
2. Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain
3. Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
4. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) Needle
5. FluoroPharma, Inc. to Report Preclinical Data on Alzheimers Disease and Prostate Cancer PET Imaging Agents
6. Teliks Proteasome Inhibitor Program Meets a Preclinical Development Milestone
7. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
8. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
9. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
10. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
11. Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Cognitive Computing for Cancer has revolutionized ... previously unattainable level of personalized treatment options with ... is anticipated that the Global Cancer Cognitive Computing ... The growth of the market is likely to ... installation of cognitive computing software in hospitals, increasing ...
(Date:2/21/2017)... 2017 Scientists From Two Companies ... Plastic Industry  ... STEER, creator of advanced materials platform ... fields of plastics, pharmaceuticals, food and nutraceuticals, biomaterials and biorefining, ... Germany , a leading science & ...
(Date:2/21/2017)... Research and Markets has announced the addition of the "Global ... report to their offering. ... The Global Apheresis Equipment Market is poised to grow ... reach approximately $4.5 billion by 2025.  This industry ... segments on global as well as regional levels presented in the ...
Breaking Medicine Technology:
(Date:2/21/2017)... ... February 21, 2017 , ... Support of value-based care models requires collaboration across ... data across industry solutions, Fogo Data Centers announces the launch of the Fogo Partner ... community is one in which all systems work well, work together, and work together ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... the further expansion of its eHealth App xChange™, providing clinical researchers more ... Bioclinica’s extensive and growing eHealth platform. Applications that enable patient-centered clinical trials ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... the predictive analytic firm Predixion’s Healthcare IT practice. Predixion, which raised $42M+ to ... backed by giants including Accenture, GE Ventures, and Software AG , will ...
(Date:2/21/2017)... ... February 21, 2017 , ... One of the most ... medical, mental health, and financial consequences of inaction. On March 3, World Hearing ... they have concerns about their hearing. , Effective treatment in the form of ...
(Date:2/21/2017)... (PRWEB) , ... February 21, 2017 , ... ... coffee house-caliber protein espresso drinks, announced its products are now available for purchase ... Coffee Protein Drink Mix has become popular among health-conscious consumers who love coffee ...
Breaking Medicine News(10 mins):